This inventor holds 7 USPTO granted patents and 6 published patent applications, plus 1 CIPO patent and 2 EPO patents. Top assignees: Alkermes Pharma Ireland Limited, Elan Pharma International Limited. Active years: 2003-2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Collegeville, PA (US) (2003)
- Gilbertsville, PA (US) (2011)
- Trooper, PA (US) (2006 - 2015)
Company Filing History:
4 out of 164 
3 out of 80 Years Active: 2003-2015
Title: The Innovations of Douglas C. Hovey
Introduction
Douglas C. Hovey is a notable inventor based in Gilbertsville, PA, with a remarkable portfolio of seven patents. His work primarily focuses on advancements in pharmaceutical formulations, particularly in nanoparticulate technologies.
Latest Patents
Among his latest innovations are nanoparticulate megestrol formulations. These inventions are directed towards creating nanoparticulate compositions that comprise megestrol, with the megestrol particles having an effective average particle size of less than about 2000 nm. This technology has the potential to enhance the delivery and efficacy of megestrol in various medical applications.
Career Highlights
Throughout his career, Douglas has contributed significantly to the pharmaceutical industry. He has worked with prominent companies such as Alkermes Pharma Ireland Limited and Elan Pharma International Limited, where he has applied his expertise in drug formulation and development.
Collaborations
Douglas has collaborated with several professionals in his field, including John Dallas Pruitt and Tuula Ryde. These partnerships have likely enriched his work and contributed to the success of his innovations.
Conclusion
Douglas C. Hovey's contributions to the field of pharmaceutical formulations, particularly through his nanoparticulate megestrol innovations, highlight his role as a significant inventor. His work continues to influence advancements in drug delivery systems.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile